757602

0

INFLUX

img img img img
No Data Available

Influx Healthtech Ltd Share Price Update

INFLUX HEALTHTECH LIMITED is trading at ₹268.9 in today's session, up by ₹8.19 or 3.14% from its previous close, with an intraday range of ₹253.20 – ₹270.00. Over the past six months, the stock has delivered a return of 113.07%. In the last month, it has returned 33.11%.

Influx Healthtech Ltd performance

Today’s low Today’s high
₹ 253.20 ₹ 270.00
₹ 268.90
52 week low 52 week high
₹ 120.00 ₹ 290.00
₹ 268.90
Open Price ₹ 264.00
Prev. Close ₹ 260.70
Volume (Shares) 18000.00
Total traded value ₹ 48.40
Upper Circuit ₹ 312.80
Lower Circuit ₹ 208.60
info

Investment Returns

Over 1 Month 33.11% Over 3 Months 25.53% Over 6 Months 48.31% Over 1 Year 113.07%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Influx Healthtech Ltd fundamentals


  • Market cap (Cr) 622.50
  • P/E Ratio (TTM) 46.60
  • Beta 1.27
  • Book Value / share 36.34
  • Return on equity 45.38%
  • EPS (TTM) 5.77
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

Influx Healthtech Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 104.85
Operating Expense 87.28
Net Profit 13.27
Net Profit Margin (%) 12.65
Earnings Per Share (EPS) 7.31
EBITDA 20.70
Effective Tax Rate (%) 25.07
Particulars MAR 2024 (Values in Cr)
Revenue 99.97
Operating Expense 85.08
Net Profit 11.13
Net Profit Margin (%) 11.13
Earnings Per Share (EPS) 6.13
EBITDA 17.00
Effective Tax Rate (%) 25.45
Particulars MAR 2023 (Values in Cr)
Revenue 76.06
Operating Expense 66.32
Net Profit 7.20
Net Profit Margin (%) 9.46
Earnings Per Share (EPS) 3.96
EBITDA 10.73
Effective Tax Rate (%) 26.07
Particulars MAR 2025 (Values in Cr)
Book Value / Share 19.91
ROE % 45.38
ROCE % 59.59
Total Debt to Total Equity 0.01
EBITDA Margin 19.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 9111.76
ROE % 64.63
ROCE % 83.91
Total Debt to Total Equity 0.03
EBITDA Margin 17.02
Particulars MAR 2023 (Values in Cr)
Book Value / Share 4660.60
ROE % 88.94
ROCE % 110.05
Total Debt to Total Equity 0.09
EBITDA Margin 14.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1810.16
ROE % 197.37
ROCE % 236.36
Total Debt to Total Equity 0.13
EBITDA Margin 8.97
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.91
Total Assets 70.29
Total Liabilities 70.29
Total Equity 36.14
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 19.01
Return on Capital (%) 36.76
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.60
Total Assets 41.10
Total Liabilities 41.10
Total Equity 22.77
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 27.07
Return on Capital (%) 48.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.54
Total Assets 28.30
Total Liabilities 28.30
Total Equity 11.65
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.42
Return on Capital (%) 57.8
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.46
Total Assets 17.58
Total Liabilities 17.58
Total Equity 4.52
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.61
Return on Capital (%) 88.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 0.02
Total Liabilities 0.02
Total Equity 0.02
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -19.51
Return on Capital (%) -21
Particulars MAR 2025 (Values in Cr)
Net Income 17.87
Cash from Operations 11.49
Cash from Investing -8.64
Cash from Financing -0.10
Net change in Cash -1.69
Free Cash Flow 19.70
Particulars MAR 2024 (Values in Cr)
Net Income 14.93
Cash from Operations 11.89
Cash from Investing -8.35
Cash from Financing -0.52
Net change in Cash 0.05
Free Cash Flow 20.25
Particulars MAR 2023 (Values in Cr)
Net Income 9.73
Cash from Operations 9.35
Cash from Investing -4.87
Cash from Financing 0.13
Net change in Cash 2.08
Free Cash Flow 14.23
Particulars MAR 2022 (Values in Cr)
Net Income 6.07
Cash from Operations 5.56
Cash from Investing -3.41
Cash from Financing 0.56
Net change in Cash 1.44
Free Cash Flow 8.43
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.02
Net change in Cash 0.02
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.77 1.65 243.69 23.12 40.44
BLISS GVS PHARMA LTD. 276.25 26.41 2.58 2922.42 105.05 280.20
CIPLA LTD 1309.90 22.25 3.21 105811.45 1165.55 1672.20
FERMENTA BIOTECH LIMITED 311.40 10.36 2.34 916.48 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2335.60 39.34 23.16 39566.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 30.58 4.43 243.69 23.12 40.44
AMRUTAJAN HEALTH LTD 570.45 28.52 4.82 1649.21 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8217.20 98.75 25.71 20543.00 7630.00 10653.05
BLISS GVS PHARMA LTD. 276.25 37.64 2.64 2922.42 105.05 280.20

Influx Healthtech Ltd shareholding pattern

Holding
24.56%
73.53%
1.83%
0.06%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Influx Healthtech Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
268.90 3.14 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 260.80
  • 26 Days 242.00
  • 10 Days 255.90
  • 50 Days 232.00
  • 12 Days 253.70
  • 100 Days 220.60
  • 20 Days 246.20
  • 200 Days 200.60
257.97 PIVOT
First Support 252.98 First Resistance 265.68 Second Support 245.27 Second Resistance 270.67 Third Support 240.28 Third Resistance 278.38
RSI 65.27 ADX 26.07 MACD 11.75 Williams % R -28.13 Commodity Channel Index (CCI) 83.83
Date 2026-04-30 Week 27100.00 Same Day 12600.00 Month 34200.00
1 Year 1.28 3 Year 1.25
Over 1 Month
33.11% down
Over 1 Year
113.07% down
Over 3 Months
25.53% down
Over 3 Years
0.00% down
Over 6 Months
48.31% down
Over 5 Years
0.00% down

Influx Healthtech Ltd Corporate Actions

Top Gainers

Top Losers

Influx Healthtech Ltd Share Price

Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre. Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai.

Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc. for the Nutraceuticals, Cosmetics, Ayurvedic / Herbal, Veterinary Feed Supplements and Homecare segment.

The Company is majorly involved in the manufacturing of Dietary/Nutritional Supplements, Gym/Sports Supplements, Veterinary Feeds, Liquid fill capsules, Ayurvedic products and homecare products for small and medium marketing and distribution brands. It specialized in manufacturing of dietary and nutritional supplements and which supports their clients during the product development phase and manufacturing of products which can further be processed into distribution and marketing by different brands.

The Company operates three manufacturing plants located in Thane, Maharashtra, which are certified with GMP, HACCP, ISO 22000, and Halal, and are equipped with advanced machinery, a quality control department, and a skilled workforce. It works as a Contract Development and Manufacturing Organization (CDMO), which is a third-party manufacturer. It specialize in a diverse products across several segments, including Dietary/Nutritional Supplements, Cosmetics, Ayurvedic / Herbal, Veterinary Feed Supplements, and Homecare segment. This includes the production of Active Pharmaceutical Ingredients (APIs) and the manufacturing of finished dosage forms such as tablets, capsules, and injectables.

The Company came up with a public issue of 61,00,800 equity shares of face value of Rs 10 each by raising funds aggregating to Rs 58.56 crore comprising a fresh issue of 50,00,400 equity shares aggregating to Rs 48 Crore and 11,00,400 equity shares aggregating to Rs 10.56 Crore via offer for sale in June, 2025.

Parent organization Indian Private
NSE symbol INFLUX
Founded 2020
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Influx Healthtech Ltd?

Answer Field

Influx Healthtech Ltd share price is for NSE ₹ 268.90 & for BSE ₹ 0.00 as on Apr 30 2026 03:23 PM.

What is the Market Cap of Influx Healthtech Ltd Share?

Answer Field

The market cap of Influx Healthtech Ltd for NSE ₹ 622.50 & for BSE ₹ 0.00 as on Apr 30 2026 03:23 PM.

What is the 52 Week High and Low of Influx Healthtech Ltd?

Answer Field

The 52 Week High and Low of Influx Healthtech Ltd for NSE is ₹ 290.00 and ₹ 120.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Influx Healthtech Ltd?

Answer Field

The 1 year returns on the stock has been 113.07%.

What is the P/E Ratio of Influx Healthtech Ltd Share?

Answer Field

As on Apr 30 2026 03:23 PM the price-to-earnings (PE) ratio for Influx Healthtech Ltd share is 46.60.

What is the PB ratio of Influx Healthtech Ltd Share?

Answer Field

As on Apr 30 2026 03:23 PM, the price-to-book (PB) ratio for Influx Healthtech Ltd share is 36.34.

How to Buy Influx Healthtech Ltd Share?

Answer Field

You can trade in Influx Healthtech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Influx Healthtech Ltd Share on Bajaj Broking App?

Answer Field

To buy Influx Healthtech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Influx Healthtech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|